Get Real Time Here
| Open0.203 | Close- |
| Vol / Avg.418.385K / 797.692K | Mkt Cap2.621M |
| Day Range0.185 - 0.207 | 52 Wk Range0.116 - 2.680 |
Sonoma Pharmaceuticals Stock (NASDAQ:SNOA), Quotes and News Summary
Sonoma Pharmaceuticals Stock (NASDAQ: SNOA) stock price, news, charts, stock research, profile.
| Open0.203 | Close- |
| Vol / Avg.418.385K / 797.692K | Mkt Cap2.621M |
| Day Range0.185 - 0.207 | 52 Wk Range0.116 - 2.680 |
Earnings
see more| Q3 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.240 | -0.290 | -0.0500 | ||||
| REV | 3.480M | 2.731M | -749.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-05 | Ladenburg Thalmann | Jeff Cohen | Initiates Coverage On | Buy | Announces | - | 3.25 |
| 2018-07-20 | Benchmark | - | Assumes | Speculative Buy | Announces | - | 3.00 |
| 2018-03-06 | Maxim Group | Jason Kolbert | Downgrades | BuyHold | Removes | 7.00 | - |
| 2017-12-28 | Benchmark | - | Initiates Coverage On | Speculative Buy | Announces | - | 10.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| SNOA | Sonoma Pharmaceuticals | -2.89% | 2.6M |
| CING | Cingulate | -6.17% | 3.3M |
| BFRI | Biofrontera | 0.45% | 5.1M |
| TTNP | Titan Pharma | -7.99% | 4.1M |
| SXTP | 60 Degrees | 2.65% | 4M |
How do I buy Sonoma Pharmaceuticals (SNOA) stock?
You can purchase shares of Sonoma Pharmaceuticals (NASDAQ: SNOA) through any online brokerage.
Who are Sonoma Pharmaceuticals's (SNOA) competitors?
Other companies in Sonoma Pharmaceuticals’s space includes: Cingulate (NASDAQ:CING), Biofrontera (NASDAQ:BFRI), Titan Pharma (NASDAQ:TTNP), 60 Degrees (NASDAQ:SXTP) and Kiora Pharmaceuticals (NASDAQ:KPRX).
What is the target price for Sonoma Pharmaceuticals (SNOA) stock?
The latest price target for Sonoma Pharmaceuticals (NASDAQ: SNOA) was reported by Ladenburg Thalmann on Tuesday, September 5, 2023. The analyst firm set a price target for 3.25 expecting SNOA to rise to within 12 months (a possible 1596.24% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Sonoma Pharmaceuticals (SNOA)?
The stock price for Sonoma Pharmaceuticals (NASDAQ: SNOA) is $0.1916 last updated Today at December 8, 2023 at 5:04 PM UTC.
Does Sonoma Pharmaceuticals (SNOA) pay a dividend?
There is no dividend information for Sonoma Pharmaceuticals.
When is Sonoma Pharmaceuticals (NASDAQ:SNOA) reporting earnings?
Sonoma Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, February 13, 2024.
Is Sonoma Pharmaceuticals (SNOA) going to split?
There is no upcoming split for Sonoma Pharmaceuticals.
What sector and industry does Sonoma Pharmaceuticals (SNOA) operate in?
Sonoma Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.